Bone and Joint Health - Q3 - Oct 2018

Page 1

A SUPPLEMENT BY MEDIAPLANET DISTRIBUTED WITHIN THE IRISH INDEPENDENT OCTOBER 2018 HEALTHNEWS.IE PHOTO: GETTYIMAGES

Getting to the heart of the matter in rheumatoid arthritis 1% of the world live with rheumatoid arthritis, that’s 21 million people: 45,000 of those live in Ireland.

R

Sinead Harney

Consultant Rheumatologist Louise Murphy cANP, Davida Hehir CNS and Tommy Harty, Cork University Hospital

heumatoid arthritis (RA) is a chronic progressive autoimmune disease which affects the synovial joints predominantly of the hands and feet, in a symmetrical distribution. 1 Chronic inflammation results in progressive joint damage which results in arthralgia, joint deformity, decreased functional ability, prolonged disability and sometimes premature death. 2 It is estimated that RA affects 21 million people worldwide equating to a prevalence of 1% 3. There are about 3 million people living with RA in Europe and according to Arthritis Ireland 45,000 people suffer from the disease in this country. RA is twice as common in women as men and the usual age of onset is between 35 and 50 years. It was not until 1922 that RA was distinguished from gout and osteoarthritis, although it had featured in the paintings of artists in the seventeenth century. Rheumatoid arthritis mainly affects the synovial joints, but many patients have extra-articular manifestations which can be serious. In particular, there is a substantial excess of infection and vascular disease; 50% of deaths in RA patients are attributable to cardiovascular disease resulting in heart failure, stroke and myocardial infarction 4 which can shorten life expectancy anything from three up to 18 years5. Factors contributing to this increased risk include traditional cardiovascular (CV) risk factors such as age, gender, dyslipidaemia,

hypertension, smoking, obesity and diabetes mellitis (DM), which partially explain the excess CV risk. Comorbidities in patients with chronic diseases including RA have been shown to be under-recognised and under-treated with wide variability existing between countries with respect to their prevalence, detection and compliance with recommendations for prevention and management 6. Guidelines published by the European League Against Rheumatism (EULAR) advise aggressive management of these traditional risk factors with tight RA disease management to try and combat cardiovascular disease for these patients7. As our department is similar to others in Ireland, we are engaging with others in Galway and Sligo to examine RA and CV more closely. All of this work highlights a need for more targeted treatment of cardiovascular risk and has led us to consider establishing an ANP-led cardiac clinic here in Cork University Hospital to address this deficit. A cross sectional study performed recently in our unit showed that for the most part RA patients cardiovascular risk was grossly under treated hence the need for an ANP led clinic.

1: ALETAHA ET AL 2010 2: SCHEINECKER AL 2008 3: SHAPIRA ET AL 2010 4: 2·68//,9$1 5: SOLOMON ET AL 2003 6: '28*$'$6 (7 $/ 7: $*&$ (7 $/ IMAGE:

Live the life you love

Contains 100% natural Rosehip and Vitamin C

Helps maintain healthy & flexible joints


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.